Skip to main content

iShares Biotechnology ETF ETF

  • IBB
  • Sector equity
  • Health care
  • BlackRock
  • Tracks the NYSE Biotechnology Index Spliced
$210.56−0.91%Close 16 Nov 2026 · Holdings as of 13 Nov 2026
Net assets
$11.0B
Holdings
248
Ten largest
51.5%
Return · 1 year
+28.2%
52-week range$160.41 — $221.13

Price close 16 Nov 2026

+1.5%1 monthHigh $221.13Low $201.99
$200$205$210$215$220$22523 Oct29 Oct4 Nov10 Nov16 Nov
+26.2%6 monthsHigh $221.13Low $164.03
$160$180$200$220$2404 Jun2 Jul30 Jul26 Aug23 Sep20 Oct16 Nov
+24.8%year to dateHigh $221.13Low $160.41
$160$180$200$220$24011 Feb30 Mar14 May1 Jul17 Aug1 Oct16 Nov
+28.2%1 yearHigh $221.13Low $160.41
$160$180$200$220$240Jan 26Mar 26Apr 26Jun 26Aug 26Sep 26Nov 26
+78.4%3 yearsHigh $221.13Low $112.02
$100$150$200$250Apr 24Sep 24Feb 25Aug 25Jan 26Jun 26Nov 26
+122%10 yearsHigh $221.13Low $88.46
$50$100$150$200$250Apr 18Sep 19Feb 21Jul 22Jan 24Jun 25Nov 26
1M
+1.5%
6M
+26.2%
YTD
+24.8%
1Y
+28.2%
3Y
+78.4%
10Y
+122%

Price change over each period, from daily closes; dividends not included.

iShares Biotechnology ETF (IBB) is a health care sector equity exchange-traded fund from BlackRock, tracking the NYSE Biotechnology Index Spliced.

It holds 248 positions, the ten largest 51.5% of the fund.

Its net assets were $11.0 billion on November 13, 2026; it is the 3rd largest of the 4 health care funds among the 300 largest ETFs.

From the fund's prospectus and its latest holdings (13 Nov 2026), compiled and checked by AapWire.

Where the money is 100% of the stocks classified

iShares Biotechnology ETF sectors
Health Care100.0%

The eleven sectors of the company pages: an S&P 500 member counts in its index sector, any other holding in its industry's; shares of the stock that has a sector.

Countries as the fund reports them: US 89.5%, BE 3.8%, CN 2.8%, DK 2.0%, DE 0.6%, FR 0.4%.

Key facts

iShares Biotechnology ETF key facts
CategoryHealth care · Sector equity
IssuerBlackRock
IndexNYSE Biotechnology Index Spliced
Expense ratio—
Net assets$11.0B · 13 Nov 2026
Holdings248 · ten largest 51.5%
Legal formRegistered fund
Rank in category3 of 4 · by size, among the 300 largest ETFs

Questions

What index does IBB track?

IBB tracks the NYSE Biotechnology Index Spliced.

How many holdings does IBB have?

IBB held 248 positions on November 13, 2026.

What are IBB's largest holdings?

Gilead Sciences (9.0%), Amgen Inc (8.5%), Vertex Pharmaceuticals (7.8%), Regeneron Pharmaceuticals (6.6%), Moderna (5.7%).

Who issues IBB?

IBB is issued by BlackRock; it is a registered fund.

In the terminal

Everything on IBB: daily holdings, flows, premium or discount and every stock it holds.

  • Flows in and out of the fund, a week to a year
  • Premium or discount to net asset value
  • The same index for less, and peers by category
See plans

Other health care funds

The fund's costs and returns are read from its prospectus, its positions from its latest report or its issuer's own file, and its category from what it holds and how it names itself. A figure that cannot be read is left blank. See data and methodology.